Back to 
Man Group plc
Man Group plc
STOK
Showing 0 of 7 quarters
Position history for Man Group plc's holdings in STOKE THERAPEUTICS INC
No. Man Group exited its STOK (Stoke Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 15,361 shares worth $80,799. Man Group first reported STOK in Q3 2022 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.